ADD ANI AS A TRUSTED SOURCE
googleads
Menu
Asia

Pakistan's ATC awards 4738 yrs imprisonment to TLP's leader, activists

Rawalpindi [Pakistan], Jan 17 (ANI): Pakistan's Anti Terrorism Court (ATC) has awarded 4,738 years of imprisonment and imposed a fine of Rs 13 million on Tehreek-e-Labbaik Pakistan (TLP) chief Khadim Hussain Rizvi's brother and nephew and 87 other activists.

ANI Jan 17, 2020 11:24 IST googleads

Tehreek-e-Labbaik Pakistan (TLP) chief Khadim Hussain Rizvi

Rawalpindi [Pakistan], Jan 17 (ANI): Pakistan's Anti Terrorism Court (ATC) has awarded 4,738 years of imprisonment and imposed a fine of Rs 13 million on Tehreek-e-Labbaik Pakistan (TLP) chief Khadim Hussain Rizvi's brother and nephew and 87 other activists.
The court has also ordered to confiscate all moveable and immoveable property of all accused, reported The News International.
The order was delivered by Rawalpindi Judge Shaukat Kamal Dar late in the night on Thursday.
The court has awarded 55 years imprisonment and imposed a fine of Rs 1,35000 for each accused. In case of non-payment of fine, the accused will face extra imprisonment of 146 years.
There was high security all around in ATC Rawalpindi at the time of decision.
As the court gave the decision, police and Elite Force/Special Branch officials loaded all accused in three buses to shift them to the Attock Jail.
On November 24, 2018, police arrested TLP chief Khadim Hussain Rizvi, his brother Ameer Hussain Rizvi, his nephew Muhammad Ali, besides 87 other religious activists, on charges of creating unrest.
The arrests had been made after TLP led a protest, which lasted for days and included several other political parties. The sit-ins were against the Supreme Court's decision to release Asiya Bibi, a Christian woman on death row since 2010, acquitting her of blasphemy charges. The protests were ended after the government and the religious parties reached a 4-point agreement. (ANI)

Get the App

What to Read Next

Europe

Blasphemy laws in Pakistan target religious minorities: GHRD

Blasphemy laws in Pakistan target religious minorities: GHRD

At the 61st session of the United Nations Human Rights Council, the organisation Global Human Rights Defence (GHRD) raised concerns over the continued misuse of blasphemy laws in Pakistan and their impact on religious minorities.

Read More
Europe

ECO FAWN Society raises Pahalgam terror attack at UN Human Rights

ECO FAWN Society raises Pahalgam terror attack at UN Human Rights

At the 61st session of the United Nations Human Rights Council (UNHRC), Yasser Laaroussi, from the ECO FAWN Society, during General Debate under Item 3, in his oral statement, highlighted the terrorist attack that took place in Pahalgam on April 22, 2025. He urged the international community to intensify efforts to combat terrorism and ensure accountability for attacks targeting civilians

Read More
Asia

MEA rejects Pakistan’s statement on India-Canada deal

MEA rejects Pakistan’s statement on India-Canada deal

"We reject this statement made by Pakistan on the matter. India's credentials regarding non-proliferation are impeccable and well recognised by the global community. A country with a well-documented history of clandestine nuclear proliferation can hardly preach the virtues of export controls and proliferation risks. Such ludicrous statements are nothing more than an attempt by Pakistan to distract from its own abysmal record," he said.

Read More
Asia

India rejects Pakistan's "baseless allegations"

India rejects Pakistan's

India on Thursday rejected Pakistan's allegations of aggravating skirmishes with Afghanistan, calling them "baseless" and accusing Pakistan of blaming others for its own misdeeds.

Read More
Asia

Policy delays leave Pakistan short of critical medicines

Policy delays leave Pakistan short of critical medicines

Pakistan faces a severe shortage of life-saving medicines, including cancer drugs and vaccines, due to government delays in notifying official prices. While global supply remains stable, regulatory hurdles have stalled legal imports, raising concerns over patient survival and the potential rise of unregulated, counterfeit medicines.

Read More
Home About Us Our Products Advertise Contact Us Terms & Condition Privacy Policy

Copyright © aninews.in | All Rights Reserved.